What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Virus
- Disease
Mel Krajden mainly investigates Immunology, Virology, Internal medicine, Hepatitis C and Hepatitis C virus.
His Immunology research is multidisciplinary, incorporating elements of Incidence and Intensive care medicine.
Virology and Interim are commonly linked in his work.
His research integrates issues of Ribavirin, Gynecology and Gastroenterology in his study of Internal medicine.
His biological study spans a wide range of topics, including Pharmacotherapy, Quality of life, Antiviral therapy and Treatment failure.
The study incorporates disciplines such as Cirrhosis, Disease burden and Cohort in addition to Hepatitis C virus.
His most cited work include:
- The Genome Sequence of the SARS-associated Coronavirus (1741 citations)
- Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study (981 citations)
- Identification of Severe Acute Respiratory Syndrome in Canada (977 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Virology, Hepatitis C, Hepatitis C virus and Immunology.
His research in Internal medicine intersects with topics in Gastroenterology, Ribavirin and Oncology.
Mel Krajden frequently studies issues relating to Genotype and Virology.
His studies in Hepatitis C integrate themes in fields like Hepatitis B, Epidemiology, Cohort study, Public health and Cohort.
His study in Hepatitis C virus is interdisciplinary in nature, drawing from both Liver disease, Hepatocellular carcinoma and Disease burden.
His Immunology research incorporates themes from Odds ratio and Hazard ratio.
He most often published in these fields:
- Internal medicine (34.30%)
- Virology (31.10%)
- Hepatitis C (29.36%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (34.30%)
- Cohort (17.15%)
- Hepatitis C virus (24.13%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Cohort, Hepatitis C virus, Hepatitis C and Hepatitis.
His work deals with themes such as Hcv treatment, Cytology and Oncology, which intersect with Internal medicine.
His Cohort study incorporates themes from Men who have sex with men, Incidence, Retrospective cohort study, Public health and Direct acting.
His Hepatitis C virus research incorporates elements of Epidemiology and Transplantation.
His Hepatitis C study also includes
- Cohort study which intersects with area such as Risk factor,
- Hepatitis B virus most often made with reference to Coinfection.
His Vaccination study results in a more complete grasp of Virology.
Between 2017 and 2021, his most popular works were:
- Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study (436 citations)
- Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial (90 citations)
- Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018 (64 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Virus
- Disease
Mel Krajden mainly focuses on Internal medicine, Virology, Hepatitis C, Cohort and Hepatitis C virus.
His Internal medicine research includes elements of Cytology and Oncology.
His Virology study integrates concerns from other disciplines, such as Pandemic, Coronavirus disease 2019, Coronavirus and Severe acute respiratory syndrome coronavirus 2.
He interconnects Hepatitis B, Chronic hepatitis, Cohort study and Hepatocellular carcinoma in the investigation of issues within Hepatitis C.
His Hepatitis B research is multidisciplinary, relying on both Disease burden and Hepatitis B virus.
His Cohort study combines topics from a wide range of disciplines, such as Medical prescription, Prescription drug and Hepatitis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
